Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Jan;35(1):152–160. doi: 10.1128/jcm.35.1.152-160.1997

Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance.

Y De Gheldre 1, N Maes 1, F Rost 1, R De Ryck 1, P Clevenbergh 1, J L Vincent 1, M J Struelens 1
PMCID: PMC229529  PMID: 8968898

Abstract

Molecular typing was used to investigate an outbreak of infection caused by multidrug-resistant Enterobacter aerogenes (MREA) susceptible only to gentamicin and imipenem in an intensive care unit (ICU). Over a 9-month period, ciprofloxacin-resistant E. aerogenes isolates were isolated from 34 patients, or 4.1% of ICU admissions, compared with a baseline rate of 0.1% in the previous period (P < 0.001). Infection developed in 15 (44%) patients. In vivo emergence of imipenem resistance (MIC, 32 micrograms/ml) of organisms causing deep-seated infection was observed in two (13%) of these patients following prolonged therapy with imipenem and gentamicin. Arbitrarily primed PCR (AP-PCR) analysis with ERIC1R and ERIC2 primers and pulsed-field gel electrophoresis (PFGE) analysis of XbaI macrorestriction patterns concordantly showed that outbreak-associated MREA isolates were clonally related and distinct from epidemiologically unrelated strains. AP-PCR and PFGE showed discrimination indices of 0.88 and 0.98, respectively. Space-time clustering of cases within units suggests that the epidemic-related MREA isolates were transmitted on the hands of the health care personnel. A case-control study and repeated environmental culture surveys failed to identify a common source or procedure associated with transmission. In spite of the early implementation of isolation measures, the incidence of MREA colonization remained stable until all colonized patients were discharged. This study confirms the usefulness of AP-PCR and PFGE analyses for the epidemiological study of E. aerogenes and underscores the difficulty of controlling the spread of multiresistant clones of this organism in the ICU setting. The emergence of imipenem resistance represents a threat because virtually no therapeutic option is available for such strains.

Full Text

The Full Text of this article is available as a PDF (296.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chow J. W., Shlaes D. M. Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes. J Antimicrob Chemother. 1991 Oct;28(4):499–504. doi: 10.1093/jac/28.4.499. [DOI] [PubMed] [Google Scholar]
  2. Davin-Regli A., Monnet D., Saux P., Bosi C., Charrel R., Barthelemy A., Bollet C. Molecular epidemiology of Enterobacter aerogenes acquisition: one-year prospective study in two intensive care units. J Clin Microbiol. 1996 Jun;34(6):1474–1480. doi: 10.1128/jcm.34.6.1474-1480.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davin-Regli A., Saux P., Bollet C., Gouin F., De Micco P. Investigation of outbreaks of Enterobacter aerogenes colonisation and infection in intensive care units by random amplification of polymorphic DNA. J Med Microbiol. 1996 Feb;44(2):89–98. doi: 10.1099/00222615-44-2-89. [DOI] [PubMed] [Google Scholar]
  4. Ehrhardt A. F., Sanders C. C., Thomson K. S., Watanakunakorn C., Trujillano-Martin I. Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatin. Clin Infect Dis. 1993 Jul;17(1):120–122. doi: 10.1093/clinids/17.1.120. [DOI] [PubMed] [Google Scholar]
  5. Garner J. S., Jarvis W. R., Emori T. G., Horan T. C., Hughes J. M. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988 Jun;16(3):128–140. doi: 10.1016/0196-6553(88)90053-3. [DOI] [PubMed] [Google Scholar]
  6. Gaston M. A. Enterobacter: an emerging nosocomial pathogen. J Hosp Infect. 1988 Apr;11(3):197–208. doi: 10.1016/0195-6701(88)90098-9. [DOI] [PubMed] [Google Scholar]
  7. Gaston M. A., Strickland M. A., Ayling-Smith B. A., Pitt T. L. Epidemiological typing of Enterobacter aerogenes. J Clin Microbiol. 1989 Mar;27(3):564–565. doi: 10.1128/jcm.27.3.564-565.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Georghiou P. R., Hamill R. J., Wright C. E., Versalovic J., Koeuth T., Watson D. A., Lupski J. R. Molecular epidemiology of infections due to Enterobacter aerogenes: identification of hospital outbreak-associated strains by molecular techniques. Clin Infect Dis. 1995 Jan;20(1):84–94. doi: 10.1093/clinids/20.1.84. [DOI] [PubMed] [Google Scholar]
  9. Grattard F., Pozzetto B., Tabard L., Petit M., Ros A., Gaudin O. G. Characterization of nosocomial strains of Enterobacter aerogenes by arbitrarily primed-PCR analysis and ribotyping. Infect Control Hosp Epidemiol. 1995 Apr;16(4):224–230. doi: 10.1086/647094. [DOI] [PubMed] [Google Scholar]
  10. Hopkins J. M., Towner K. J. Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenes. J Antimicrob Chemother. 1990 Jan;25(1):49–55. doi: 10.1093/jac/25.1.49. [DOI] [PubMed] [Google Scholar]
  11. Hunter P. R., Gaston M. A. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J Clin Microbiol. 1988 Nov;26(11):2465–2466. doi: 10.1128/jcm.26.11.2465-2466.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lee E. H., Nicolas M. H., Kitzis M. D., Pialoux G., Collatz E., Gutmann L. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem. Antimicrob Agents Chemother. 1991 Jun;35(6):1093–1098. doi: 10.1128/aac.35.6.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Livermore D. M. beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev. 1995 Oct;8(4):557–584. doi: 10.1128/cmr.8.4.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Maes P., Vanhoof R. A 56-month prospective surveillance study on the epidemiology of aminoglycoside resistance in a Belgian general hospital. Scand J Infect Dis. 1992;24(4):495–501. doi: 10.3109/00365549209052636. [DOI] [PubMed] [Google Scholar]
  15. Manian F. A., Meyer L., Jenne J., Owen A., Taff T. Loss of antimicrobial susceptibility in aerobic gram-negative bacilli repeatedly isolated from patients in intensive-care units. Infect Control Hosp Epidemiol. 1996 Apr;17(4):222–226. doi: 10.1086/647284. [DOI] [PubMed] [Google Scholar]
  16. Meyers H. B., Fontanilla E., Mascola L. Risk factors for development of sepsis in a hospital outbreak of Enterobacter aerogenes. Am J Infect Control. 1988 Jun;16(3):118–122. doi: 10.1016/0196-6553(88)90050-8. [DOI] [PubMed] [Google Scholar]
  17. Neu H. C. Resistance of Pseudomonas aeruginosa to imipenem. Infect Control Hosp Epidemiol. 1992 Jan;13(1):7–9. doi: 10.1086/646416. [DOI] [PubMed] [Google Scholar]
  18. Neuwirth C., Siebor E., Lopez J., Pechinot A., Kazmierczak A. Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae. J Clin Microbiol. 1996 Jan;34(1):76–79. doi: 10.1128/jcm.34.1.76-79.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Panhotra B. R., Bhardwaj G., Naqash H. U., Desai B. Isolation and survival of gentamicin resistant Enterobacter aerogenes on finger tips of hospital personnel. Zentralbl Hyg Umweltmed. 1989 Jun;188(3-4):331–335. [PubMed] [Google Scholar]
  20. Struelens M. J., Carlier E., Maes N., Serruys E., Quint W. G., van Belkum A. Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting. J Hosp Infect. 1993 Sep;25(1):15–32. doi: 10.1016/0195-6701(93)90005-k. [DOI] [PubMed] [Google Scholar]
  21. Struelens M. J., Rost F., Deplano A., Maas A., Schwam V., Serruys E., Cremer M. Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am J Med. 1993 Nov;95(5):489–498. doi: 10.1016/0002-9343(93)90331-i. [DOI] [PubMed] [Google Scholar]
  22. Tzouvelekis L. S., Tzelepi E., Kaufmann M. E., Mentis A. F. Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes. J Med Microbiol. 1994 Jun;40(6):403–407. doi: 10.1099/00222615-40-6-403. [DOI] [PubMed] [Google Scholar]
  23. Tzouvelekis L. S., Tzelepi E., Mentis A. F., Vatopoulos A. C., Tsakris A. Imipenem resistance in Enterobacter aerogenes is associated with derepression of chromosomal cephalosporinases and impaired permeability. FEMS Microbiol Lett. 1992 Aug 15;74(2-3):195–199. doi: 10.1016/0378-1097(92)90428-q. [DOI] [PubMed] [Google Scholar]
  24. Versalovic J., Koeuth T., Lupski J. R. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 1991 Dec 25;19(24):6823–6831. doi: 10.1093/nar/19.24.6823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Vincent J. L., Bihari D. J., Suter P. M., Bruining H. A., White J., Nicolas-Chanoin M. H., Wolff M., Spencer R. C., Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995 Aug 23;274(8):639–644. [PubMed] [Google Scholar]
  26. de Champs C., Henquell C., Guelon D., Sirot D., Gazuy N., Sirot J. Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem. J Clin Microbiol. 1993 Jan;31(1):123–127. doi: 10.1128/jcm.31.1.123-127.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. de Champs C., Sirot D., Chanal C., Poupart M. C., Dumas M. P., Sirot J. Concomitant dissemination of three extended-spectrum beta-lactamases among different Enterobacteriaceae isolated in a French hospital. J Antimicrob Chemother. 1991 Apr;27(4):441–457. doi: 10.1093/jac/27.4.441. [DOI] [PubMed] [Google Scholar]
  28. van Belkum A. DNA fingerprinting of medically important microorganisms by use of PCR. Clin Microbiol Rev. 1994 Apr;7(2):174–184. doi: 10.1128/cmr.7.2.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. van Belkum A., Struelens M., Quint W. Typing of Legionella pneumophila strains by polymerase chain reaction-mediated DNA fingerprinting. J Clin Microbiol. 1993 Aug;31(8):2198–2200. doi: 10.1128/jcm.31.8.2198-2200.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES